OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that data from the Phase 2 study of orexin receptor 2 (OX2R) agonist TAK-994 in patients with narcolepsy ...
As the England touring party prepares for South Afica, Ralph Ellis asseses the impact of some of the more controversial sqaud selections. I also think Steve Harmison should have been kept in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback